Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers.
Cytotherapy
; 22(12): 792-801, 2020 12.
Article
in En
| MEDLINE
| ID: mdl-32732084
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Risk Management
/
Pharmaceutical Preparations
/
T-Lymphocytes
/
Receptors, Chimeric Antigen
Type of study:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Cytotherapy
Journal subject:
TERAPEUTICA
Year:
2020
Type:
Article
Affiliation country:
France